TrialJournal of gastroenterology2008

A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease.

Michio Hongo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.